Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-30

FDA Approved: MIRABEGRON — Original Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

The FDA approved Qilu Pharmaceutical Co., Ltd.'s generic mirabegron (ANDA 217989) for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)

Snippet

ORIG AP for MIRABEGRON (MIRABEGRON)